1. Accelerated whole breast irradiation in early breast cancer patients with adverse prognostic features
- Author
-
Kyung Hwan Shin, Seock-Ah Im, Tae Hyun Kim, Soo Yoon Sung, Dong Young Noh, Eui Kyu Chie, Hyeon Woo Lim, Sea Won Lee, Wonshik Han, Kyubo Kim, Keun Seok Lee, Jin Ho Kim, and Eun Sook Lee
- Subjects
Oncology ,Adult ,medicine.medical_specialty ,Time Factors ,Seoul ,medicine.medical_treatment ,Breast Neoplasms ,Mastectomy, Segmental ,Disease-Free Survival ,03 medical and health sciences ,0302 clinical medicine ,Breast cancer ,Whole Breast Irradiation ,Risk Factors ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Risk factor ,Stage (cooking) ,early breast cancer ,Early breast cancer ,Aged ,Neoplasm Staging ,Gynecology ,Aged, 80 and over ,business.industry ,hypofractionation ,Hazard ratio ,Cancer ,Middle Aged ,medicine.disease ,Radiation therapy ,Ki-67 Antigen ,Treatment Outcome ,risk factor ,030220 oncology & carcinogenesis ,Disease Progression ,Female ,Radiotherapy, Adjuvant ,Dose Fractionation, Radiation ,Neoplasm Grading ,Neoplasm Recurrence, Local ,Radiotherapy, Conformal ,Clinical Research Paper ,business - Abstract
// Sea-Won Lee 1,3 , Kyung Hwan Shin 1 , Eui Kyu Chie 1 , Jin Ho Kim 1 , Seock-Ah Im 1 , Wonshik Han 1 , Dong-Young Noh 1 , Hyeon Woo Lim 2 , Tae Hyun Kim 2 , Keun Seok Lee 2 , Eun Sook Lee 2 , Soo Yoon Sung 3 and Kyubo Kim 4 1 Seoul National University, College of Medicine, Seoul, Korea 2 Research Institute and Hospital, National Cancer Center, Goyang, Korea 3 Catholic University of Korea, College of Medicine, Seoul, Korea 4 Ewha Womans University, School of Medicine, Seoul, Korea Correspondence to: Kyung Hwan Shin, email: // Keywords : early breast cancer, risk factor, hypofractionation Received : June 07, 2016 Accepted : August 26, 2016 Published : August 30, 2016 Abstract Purpose: Accelerated whole breast irradiation (AWBI) and conventional whole breast irradiation (CWBI) were compared to determine whether AWBI is as effective as CWBI in patients with early breast cancer and adverse prognostic features. Patients and methods: We included 330 patients who underwent breast-conserving surgery (BCS) and post-operative radiation therapy (RT) using AWBI for pT1-2 and pN0-1a breast cancer from 2007 to 2010. These patients were matched with 330 patients who received CWBI according to stage, age (±3 years), and the year of BCS. AWBI of 39 Gy and CWBI of 50.4 Gy were given in 13 and 28 fractions, respectively. Results: Median follow-up time was 81.9 months. There were no statistically significant differences between the AWBI and CWBI groups in terms of age, stage, tumor grade, or molecular subtype. More patients with Ki-67 index ≥ 14% were present in the AWBI group (AWBI 47.0% vs. CWBI 10.3%; P
- Published
- 2016